Skip to main content
. 2024 Jun 12;25(12):6481. doi: 10.3390/ijms25126481

Figure 5.

Figure 5

Diagram of DCLK1 and DCLK1-modulated miRNAs in liver disease progression. (A) Disease progression from normal liver to fibrotic liver by elevation of miR-1246 expression, (B) Inhibition of miR-206 promotes progression to cirrhosis, and (C) elevated miR-184 promotes HCC. Created with BioRender.com (accessed on 28 May 2024).